- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- azelastine hydrochloride and fluticasone propionate, Dymista vehicle
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 4 Years to 11 Years
- Enrollment
- 348 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2013
- U.S. locations
- 31
- States / cities
- Birmingham, Alabama • Little Rock, Alaska • Atlanta, Georgia + 24 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–20
of 20
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Azelastine hydrochloride and Fluticasone propionate, Dymista™, Placebo
- Drug · Other
- Lead sponsor
- Teva Pharmaceuticals USA
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 1,535 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2014
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Allergic Rhinitis
- Interventions
- Olopatadine 0.6% / Azelastine 137 mcg
- Drug
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 102 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2008
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- Azelastine hydrochloride nasal spray 0.15%, Azelastine hydrochloride nasal spray 0.10%, Placebo
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 6 Years to 12 Years
- Enrollment
- 489 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 39
- States / cities
- Costa Mesa, California • Long Beach, California • Mission Viejo, California + 34 more
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- 0.15% azelastine hydrochloride, 0.1% azelastine hydrochloride, Placebo
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 581 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2007
- U.S. locations
- 43
- States / cities
- Huntington Beach, California • Long Beach, California • Los Angeles, California + 35 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Placebo nasal spray, 0.15% azelastine hydrochloride Nasal Spray
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older · Female only
- Enrollment
- 481 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007
- U.S. locations
- 34
- States / cities
- Huntington Beach, California • Long Beach, California • San Diego, California + 30 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Placebo, 0.15% azelastine hydrochloride
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 506 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 7
- States / cities
- Austin, Texas • New Braunfels, Texas • San Antonio, Texas + 1 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Placebo, azelastine Hcl, azelastineHcl / fluticasone propionate, fluticasone propionate
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 832 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 43
- States / cities
- Scottsdale, Arizona • Encinitas, California • Los Angeles, California + 38 more
- Conditions
- Chronic Allergic Rhinitis, Nonallergic Rhinitis
- Interventions
- Astepro Nasal Spray (0.1% azelastine hydrochloride), Astelin Nasal Spray (0.1% azelastine hydrochloride)
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 862 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- Somerset, New Jersey
- Conditions
- Allergic Rhinitis
- Interventions
- 205.5 mcg of azelastine hydrochloride, 137 mcg of azelastine hydrochloride
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 6 Months to 5 Years
- Enrollment
- 191 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Little Rock, Alaska • Costa Mesa, California + 9 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- MP29-02, azelastine Hcl, fluticasone propionate, placebo
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 607 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 7
- States / cities
- Austin, Texas • New Braunfels, Texas • San Antonio, Texas + 1 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray, Placebo nasal spray
- Drug
- Lead sponsor
- Padagis LLC
- Industry
- Eligibility
- 12 Years to 65 Years
- Enrollment
- 951 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 30
- States / cities
- Stockbridge, Georgia • Louisville, Kentucky • Baltimore, Maryland + 21 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Placebo, 0.15% Azelastine Hydrochloride
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 536 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 6
- States / cities
- Austin, Texas • New Braunfels, Texas • San Antonio, Texas + 1 more
- Conditions
- Vasomotor Rhinitis
- Interventions
- Olopatadine HCL (Patanase) Nasal Spray, 0.6%, Azelastine HCl (Astelin) Nasal Spray, 137 mcg
- Drug
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 129 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2009
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- azelastine HCl/fluticasone propionate, azelastine Hcl, fluticasone propionate, placebo
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 776 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 39
- States / cities
- Scottsdale, Arizona • Encinitas, California • Fountain Valley, California + 32 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Olopatadine HCl Nasal Spray, 0.6%, Azelastine HCl Nasal Spray, 0.1%
- Drug
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2009
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- azelastine hydrochloride 0.15% Nasal Spray, azelastine hydrochloride 0.15% and Placebo, Azelastine 0.1%, Nasal Spray
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 617 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 30
- States / cities
- Fountain Valley, California • Long Beach, California • Los Angeles, California + 26 more
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- 0.15% azelastine hydrochloride, Mometasone furoate
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 703 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 59
- States / cities
- Oxford, Alabama • Fountain Valley, California • Huntington Beach, California + 50 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- 0.15% azelastine hydrochloride 1644 mcg daily, 0.1% azelastine hydrochloride 1096 mcg daily, Placebo
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 526 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007
- U.S. locations
- 29
- States / cities
- Oxford, Alabama • Encinitas, California • Los Angeles, California + 25 more
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Placebo, azelastineHcl, fluticasone propionate, azelastine Hcl/fluticasone propionate
- Drug
- Lead sponsor
- Meda Pharmaceuticals
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 1,791 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009
- U.S. locations
- 45
- States / cities
- Scottsdale, Arizona • Encinitas, California • Fountain Valley, California + 35 more